COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

CHEST 2022 Coverage

V. Balasubramanian

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Post-Intensive Care Syndrome (PICS) / Long Haul COVID-19

Houston Methodist

C. M. Sevin, D. Bangalore Gotur

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

University of Colorado Department of Medicine

E. Wallace, J. Zell

Hair Graying and the Melanocyte: Mechanisms and Melanoma Implications

Masterclasses in Dermatology

D. Fisher

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

How to Manage: Melanonychia

EADV 2022 Conference Coverage

M. Starace

Management of Simultaneous Venous and Arterial Thromboembolic Disease

Scripps Health

J. May

Clinical Case Review: Cutaneous T Cell Lymphoma in the Patch Test Cl…

2024 Clinical Case Studies

J. Murase

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

Current Review of Benign Hematology and Coagulopathy

Indy Hematology Review

C. Kessler

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

Vanderbilt University Medical Center (VUMC)

M. Baljevic

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Prevent…

Robert McBane

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

Fred Hutchinson Cancer Center Update in Thromboembolism

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

EHA 2024 Insights: Low-Molecular-Weight Heparin and VTE in Newly Dia…

Insights from 2024 EHA Annual Meeting

M. Lauw

ASH Annual Meeting Updates in Non-Malignant/Classical Hematology

UChicago Medicine

K. Cohen

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Risk for Developing VTE in Pts With Compound Heterozygosity of FVL a…

Cleveland Clinic Taussig Cancer Institute

G. Gerber